Eiko LifeSciences Balance Sheet Health
Financial Health criteria checks 5/6
Eiko LifeSciences has a total shareholder equity of ₹513.3M and total debt of ₹4.3M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are ₹549.3M and ₹35.9M respectively. Eiko LifeSciences's EBIT is ₹11.3M making its interest coverage ratio -16.1. It has cash and short-term investments of ₹31.3M.
Key information
0.8%
Debt to equity ratio
₹4.26m
Debt
| Interest coverage ratio | -16.1x |
| Cash | ₹31.32m |
| Equity | ₹513.31m |
| Total liabilities | ₹35.95m |
| Total assets | ₹549.26m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 540204's short term assets (₹299.4M) exceed its short term liabilities (₹29.8M).
Long Term Liabilities: 540204's short term assets (₹299.4M) exceed its long term liabilities (₹6.1M).
Debt to Equity History and Analysis
Debt Level: 540204 has more cash than its total debt.
Reducing Debt: 540204's debt to equity ratio has reduced from 47.1% to 0.8% over the past 5 years.
Debt Coverage: 540204's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 540204 earns more interest than it pays, so coverage of interest payments is not a concern.